不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

山东博科
现在位置不用本金就能赚钱的方法>所有品牌>复星医药
中国 . 复星医药
Fosun Pharma

复星医药,Fosun Pharma,
不用本金就能赚钱的方法 上海复星医药(集团)股份有限公司(简称“复星医药”,证券代码600196)成立于1994 年,1998 年8 月在上海证券交易所挂牌上市,是在中国医药行业处于领先地位的上市公司。

FUXINGYIYAOSHANGSHI13NIANYILAI,JINGLIRUNZENGZHANGLE13.55BEI,NIANJUNFUHEZENGZHANGLVDADAO24.26%。XIAOSHOUSHOURU、JINGZICHAN、JINGLIRUN、GUPIAOSHIZHIJUNMINGLIEZHONGGUOYIYAOSHANGSHIGONGSIQIANLIE。

FUXINGYIYAOZHUANZHUXIANDAISHENGWUYIYAOJIANKANGCHANYE,ZHUAZHUZHONGGUOYIYAOSHICHANGDEKUAISUCHENGZHANGHEZHONGGUOQIYEJINJUNSHIJIEZHULIUYIYAOSHICHANGDEJUDAJIYU,YI“PINPAI、CHUANGXIN、GAOXIAO、QUANQIUHUA”WEIJINGYINGLINIAN,JIAKUAISHISHICHANYEZHENGHEHEZHONGBANGCHANPINZHANLVE,WENJIANJINGYING、KUAISUFAZHAN,CHENGWEILEYIYAOPINYANFAZHIZAOHEYIYAOLIUTONGWEIHEXIN,TONGSHIZAIYIXUEZHENDUAN、YILIAOQIXIEHEYILIAOFUWUDENGLINGYUYONGYOULINGXIANGUIMOHESHICHANGDIWEI,ZAIYANFACHUANGXIN、SHICHANGYINGXIAO、BINGGOUZHENGHE、RENCAIJIANSHEDENGFANGMIANXINGCHENGJINGZHENGYOUSHIDEDAXINGZHUANYEYIYAOJIANKANGCHANYEJITUAN。

FUXINGYIYAOZHUZHONGCHUANGXINYANFA,YONGYOUGUOJIAJIQIYEJISHUZHONGXIN。ZAIZHONGGUO,FUXINGYIYAOYIQUDEGANBING、TANGNIAOBING、JIEHEBING、LINCHUANGZHENDUANCHANPINDENGXIFENSHICHANGDELINGXIANDIWEI。ZAIQUANQIUSHICHANG,FUXINGYIYAOYEYICHENGWEIKANGNVEYAOWUDENGLINGYUDELINGXIANZHE。FUXINGYIYAOTOUZIDEGUOYAOKONGGUYU2009 ZAIXIANGGANGCHENGGONGSHANGSHI,CHENGWEIZHONGGUOZUIDA、QUANQIUSHIZHILINGXIANDEYIYAOLIUTONGLEISHANGSHIGONGSI。MUQIAN,GUOYAOKONGGUSHICHANGZHANYOULVYIJINGCHAOGUO10%,XIAOSHOUSHOURUCHAOCHUDIER、SANMINGZONGHE。YIYAOLINGSHOULINGYU,FUXINGYIYAOQIXIADEYAOPINLINGSHOUPINPAIGUODAYAOFANG、FUMEIDAYAOFANG、JINXIANGDAYAOFANGJIXUBAOCHIZAIGEZIQUYUSHICHANGDEPINPAILINGXIANHEYINGLINENGLILINGXIAN,XINGCHENGYISHANGHAI、BEIJINGWEIZHONGXIN,MIANXIANGQUANGUOFAZHANDEYIYAOLINGSHOUGEJU。

ZHUOYUEDESHICHANGBIAOXIANSHIFUXINGYIYAOCHENGWEIQUANQIUDINGJISHANGXUEYUANDEANLI。CHIXU、WENJIANDEFAZHANSHIFUXINGYIYAOCHENGWEIZHONGGUOSHANGSHIGONGSIZHONGDEBIAOGAN、WENJUXINGYELINGXIANDIWEI;QIYEPINPAIZAIYIYAOJIANKANGCHANYEHEZIBENSHICHANGDOUBEISHOUXINLAI。

FUXINGYIYAOFENGXINGKECHIXUFAZHANDEYUANZE,JIANGGONGSIDESHEHUIZEREN、JINGJIXIAOYIHESHENGTAIXIAOYIZHIYUTONGDENGZHONGYAODEWEIZHI。QIYEGONGMINDEZERENYIBEINARUGONGSIZHANGQIFAZHANZHANLVE。FUXINGYIYAOYIZHIZHILIYUGONGYISHIYE,JIJITOUSHENZHONGGUOGUANGCAISHIYEDEFAZHAN,JIJIXIEZHUZHONGGUOZHENGFUDUIWAIYUANZHUGONGZUO,ZAIJIAOYU、GUCANJIUZHU、ZAIHAIJIUJIDENGFANGMIANTOURUGUOYI。

面向未来,复星医药将继续以促进人类健康为使命,秉承“持续创新 共享健康”的理念,采取“内生式增长、外延式扩张和整合式发展”的战略发展手段,进一步加强在中国医药行业领先地位的同时,以创新战略为先导,面向国际、国内两个市场,打造具有国际竞争力的全球化医药健康企业。
 
复星医药Fosun Pharma  复星 Fosun






上海复星长征医学科学有限公司

地  址: 上海市宝山区城银路830号  
邮政编码: 200444
电  话: 021-60765888
传  真: 021-60765999

上海复星佰珞生物技术有限公司

总 机 :86-021-60765887
传 真 :86-021-60765881
不用本金就能赚钱的方法 免费技术服务电话 :800-820-3203

E-mail :
     信 息 咨 询  info@biofosun.com
     研 发 部    rd@biofosun.com
     市 场 部    marketing@biofosun.com
     人 力 资 源 部 hr@biofosun.com
上海复星医学科技发展有限公司
总 机:021-60765888
传 真:021-60765999
免费服务电话:
400-820-7902 800-820-7902
邮 箱:fosunmedtech@fosunpharma.com
地 址:上海市城银路830号
邮 编:200444

亚能生物技术(深圳)有限公司
地 址: 深圳市宝安区西乡兴业路互联网产业基地三层3019
深圳市南山区高新区中区高新中一道生物孵化器2-309
电 话: 0755-26031001
传 真: 0755-26031002
邮政编码: 518057
邮 箱: yanengbio@yanengbio.com
客服电话:
客服邮箱:
0755-26031054
inquire@yanengbio.com
订货电话:
订货邮箱:
0755-26031053
order@yanengbio.com

上海复星医药(集团)股份有限公司


公司地址:上海市复兴东路2号复星商务大厦         邮政编码:200010
        电 话:+86-21-23138000
        传 真:+86-21-23138052

投资者关系   联系人:乔志城 董晓娴
电话:+86-21-23138196
传真:+86-21-23138035
邮件:ir@fosunpharma.com
投资合作   电话:+86-21-23138112
电话:+86-21-23138127
邮件:invest@fosunpharma.com
国际业务   电话:+86-21-63325610
传真:+86-21-63325581
邮件:int@fosunpharma.com
商务发展(新技术、新项目合作)   联系人:智胜德
电话: 86-21-63325523
传真: 86-21-63325581
邮件:zhishd@fosunpharma.com
公共关系(媒体采访及企业刊物索取)   联系人:易锦媛
电话:+86-21-23138089
传真:+86-21-23138052
邮件:pr@fosunpharma.com
社会责任   联系人:赵烨
电话:+86-21-23138000(前台转)
传真:+86-21-23138052
邮件:pr@fosunpharma.com
人力资源(职业机会及人才管理)   电话:+86-21-23138000
传真:+86-21-23138052
邮件:zhaopin@fosunpharma.com

专注五大治疗领域 名列中国五大本土制药公司
制药业务是复星医药战略发展的核心。自2002年开始,复星医药专注于发展制药业务,从事药品的研发、生产及营销。根据IMS统计数据,目前,复星医药已跻身为中国五大本土制药公司。凭借我们在制药行业的卓越地位及坚实基础,复星医药一直坚持在药品制造方面奉行严格的质量监控标准及程序,并致力于以最新的国际标准为目标不断改善产品标准及制造程序。


公司注重研发创新,以创新药物、首仿药以及差异化的品牌仿制药为主。我们的药品主要针对中国规模最大、增长最快的五大治疗领域,即新陈代谢及消化道、心血管系统、抗肿瘤、中枢神经系统及抗感染等疾病治疗领域。现时, 我们在上海、重庆、四川、河北、广西、江苏和辽宁七个省市已经拥有18个药品生产设施,总计148条获药品生产质量管理规范认证的生产线,致力于为各地人民提供最高质量的药品。

主要制药企业
江苏万邦生化医药股份有限公司
——江苏万邦医药营销有限公司
——上海凯茂生物医药有限公司
——河北万邦复临药业有限公司
重庆药友制药有限责任公司
——四川合信药业有限责任公司
——重庆凯林制药有限公司
湖北新生源生物工程股份有限公司
邯郸摩罗丹药业股份有限公司
桂林南药有限责任公司
上海朝晖药业有限公司
沈阳红旗制药有限公司
重庆康乐制药有限公司
锦州奥鸿药业有限责任公司
大连雅立峰生物制药有限公司


主要研发企业
重庆医药工业研究院有限责任公司
上海复宏汉霖生物技术有限公司
重庆复创医药研究有限公司
上海星泰医药科技有限公司

中国药品分销、零售领先品牌
不用本金就能赚钱的方法 复星医药于2003年与中国医药集团建立战略伙伴合作关系,构建了中国医药分销第一品牌国药控股。通过与国药控股的紧密合作,我们受益于其庞大的药品分销网络、高知名度的品牌效应和全方位的物流服务,在提升整体营销效益上有令人可喜的成果。

LINGYIFANGMIAN,WOMENYITONGGUOFUXINGYAOYEFENXIAOYAOPINJIYILIAOBAOJIANCHANPIN,YIJIZHUYAOTONGGUOJINGYINGFUMEIDAYAOFANGJIJINXIANGDAYAOFANGCONGSHILINGSHOUYAOFANGYEWU,BINGYICHENGGONGYUSHANGHAIJIBEIJINGDELINGSHOUYAOFANGSHICHANGJIANLILINGXIANDIWEI。FUXINGYAOYEWEIFUMEIDAYAOFANGDEWEIYIGONGHUOSHANG,TONGSHIYIWEISHANGHAIQITALINGSHOUYAOFANG、YILIAOJIGOUJIYAOPINFENXIAOSHANGDEGONGHUOSHANG。


医药流通企业
国药控股股份有限公司(联营公司)
上海复星药业有限公司
上海复美益星大药房连锁有限公司
北京金象大药房医药连锁有限责任公司

瞄准高端、专科及综合医疗服务
不用本金就能赚钱的方法 复星医药将医疗服务作为公司未来重点发展的业务领域之一。随着中国经济的快速增长和大众的医疗保健意识日渐提高,我们预期市场未来对医疗服务的需求,尤其是在高端医疗和专科服务方面将会迅速增长。2010年,我们通过与美中互利战略性合作进入中国高端医疗服务市场,其具有国际领先水平的高端医疗服务品牌和睦家连锁医院,让我们于较高的起点快速进入了高端医疗服务领域。与此同时,我们亦通过投资安徽济民肿瘤医院、岳阳广济医院进入中国专科及综合医疗市场,从而为市民分别提供优质的医疗服务。

医疗服务企业
和睦家医疗(United Family Healthcare)(参股企业)

安徽济民肿瘤医院
岳阳广济医院

医学诊断事业部在国内较早开始专业从事体外诊断领域的多种经营,产品涉及临床化学、临床免疫、分子诊断、基因芯片技术、临床微生物等检验医学领域。拥有 “长征”、 “佰珞”、“亚能”等优势品牌,并以强大的研发队伍和博士后工作站、完善的售后网络为核心竞争力,成为中国自主研发、生产体外诊断产品最多的企业之一。

医学诊断企业
上海复星长征医学科学有限公司
上海复星医学科技发展有限公司
上海复星佰珞生物技术有限公司
亚能生物技术(深圳)有限公司

 

FUXINGYIYAOYUMEIZHONGHULIHEZICHENGLILEMEIZHONGHULIYILIAOYOUXIANGONGSI(Chindex Medical Limited,JIANCHENGCML),ZAIZHONGGUOSHENGCHAN、XIAOSHOUYILIAOQIXIEHAOCAIJIDAILIXIAOSHOUGAODUANYILIAOQIXIE,ZHUYAOCONGSHISHUXUEQICAIJISHOUSHUHAOCAIDEYANFA、ZHIZAO、XIAOSHOUJIYINGXIAO,YIJIGAODUANJINKOUYILIAOSHEBEIDEXIAOSHOUDAILI。WOMENTONGGUOCMLDEYUNYINGYOUXIAOZHENGHELEWOMENZAIZHONGGUOSHENGCHAN、XIAOSHOUYILIAOQIXIEHAOCAIDEYEWUHEMEIZHONGHULIQIXIADEGAODUANYILIAOQIXIEDEDAILIXIAOSHOUYEWU。MUQIAN,MEIZHONGHULIYILIAOYOUXIANGONGSISHIYIJIALINGXIANDEYILIAOSHEBEIGONGYINGSHANG,ZAIMEIGUOHEZHONGGUOFENBIESHEYOUYUNYINGZONGBU,GONGSIBUDUANCHAOYUEDIYUWENHUAXIANZHI,XIANGDAZHONGHUAQUDEYILIAOJIANKANGLINGYUTIGONGJIANDUANDEYILIAOJISHUHEGAOZHILIANGDECHANPIN。

医疗器械企业
不用本金就能赚钱的方法 美中互利医疗有限公司(Chindex Medical Limited)




Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196), was established in 1994 and listed on Shanghai Stock Exchange in August 1998. It is a leading listed company in Chinese pharmaceutical industry.

Specializing in modern biopharmaceutical and healthcare industry, Fosun Pharma has captured opportunities within the rapidly developing Chinese healthcarel industry as well as from the globalization of Chinese healthcare companies in general. Fosun Pharma's operations strategically cover several important segments of the healthcare industry value-chain, including: pharmaceutical manufacturing, distribution and retail. In particular, the Company has a leading market position and unmatched advantages in pharmaceutical distribution and retail, healthcare services, diagnostic products and medical devices, and maintains a strong focus on research and development, and manufacturing. As one of the largest healthcare companies in China, Fosun Pharma enjoys a competitive advantage in research and development, innovation, marketing, integration of mergers and acquisitions, as well as human resources.

As a result of its focus on innovation, research and development, Fosun Pharma maintains a highly capable international R&D team with operations in Shanghai and Chongqing and the United States in addition to its National Recognized Enterprise Technology Centre. Fosun Pharma's research and development activities cover therapeutic areas such as metabolism and alimentary tract, the cardiovascular system, oncology and immunomodulation.,nervous system and anti-infection. The Company has market-leading products in China in such segments as liver diseases, diabetes, tuberculosis and diagnostic products; and is the leading provider of anti-malaria medicines globally.

While focusing on pharmaceutical manufacturing, Fosun Pharma has built a leading position in diagnostic products and medical devices while actively developing its presence in healthcare services, where it has a solid foundation for domestic high-end and specialty services. Fosun Pharma is the second largest shareholder of Sinopharm, China's largest pharmaceutical distributor. The Company also operates leading local pharmacy chains such as For Me Pharmacy and Golden Elephant Pharmacy, which, from their bases in Shanghai and Beijing, provide it with a nationwide retail network.

Fosun Pharma strongly believes in the principle of sustainable development and has incorporated social responsibility into its long-term business strategy. In full recognition of its social role, Fosun Pharma endeavors to meet the needs of its community, customers, employees and shareholders throughout the conduct of its business and its future development.

With its commitment to innovation for good health and creating a better future, Fosun Pharma remains on its mission to promote health and well-being. The Company's strategic development approach of “Organic Growth, Coupled with M&A and Integration” allows it to continue to enhance creativity and service, drive integration and achieve global capabilities. As a result, Fosun Pharma will emerge with an effective operation, world-class management, sound investments and as a leading provider of healthcare products and services.
 

湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图